共 50 条
- [31] Selectivity and Safety of VIP943: A Novel CD123-Targeting Antibody-Drug Conjugate (ADC) Using a Proprietary Linker and Payload ClassBLOOD, 2023, 142Stelte-Ludwig, Beatrix论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma GmbH, Monheim, Germany Vincerx Pharma GmbH, Monheim, GermanySchomber, Tibor论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma GmbH, Monheim, Germany Vincerx Pharma GmbH, Monheim, GermanyIzumi, Raquel论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma, Palo Alto, CA USA Vincerx Pharma GmbH, Monheim, GermanyWong, Harvey论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma, Palo Alto, CA USA Vincerx Pharma GmbH, Monheim, GermanyFrigault, Melanie M.论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma, Palo Alto, CA USA Vincerx Pharma GmbH, Monheim, GermanyRebstock, Anne-Sophie论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma GmbH, Monheim, Germany Vincerx Pharma GmbH, Monheim, GermanyLudwig, Sebastian论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma GmbH, Monheim, Germany Vincerx Pharma GmbH, Monheim, GermanyMithal, Arushi论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma, Palo Alto, CA USA Vincerx Pharma GmbH, Monheim, GermanyJohnson, Amy J.论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma, Palo Alto, CA USA Vincerx Pharma GmbH, Monheim, GermanyHamdy, Ahmed论文数: 0 引用数: 0 h-index: 0机构: Vincerx Pharma, Palo Alto, CA USA Vincerx Pharma GmbH, Monheim, Germany
- [32] CD123CAR displays clinical activity in relapsed/refractory (r/r) acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN): Safety and efficacy results from a phase 1 study.CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 33 - 34Budde, Lihua E.论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USASong, Joo论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USADel Real, Marissa论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAKim, Young论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAToribio, Candida论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAWood, Brent论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAWagner, Jamie论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAMarcucci, Emanuela论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Berkeley, Berkeley, CA 94720 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAStein, Anthony论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAMarcucci, Guido论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USABrown, Christine E.论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USAForman, Stephen J.论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
- [33] INITIAL RESULTS FROM A FIRST-IN-HUMAN STUDY OF IMGN779, A CD33-TARGETING ANTIBODY-DRUG CONJUGATE (ADC) WITH NOVEL DNA ALKYLATING ACTIVITY, IN PATIENTS WITH RELAPSED OR REFRACTORY AMLHAEMATOLOGICA, 2017, 102 : 217 - 218Cortes, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA论文数: 引用数: h-index:机构:Wang, E.论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Buffalo, NY 14263 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAArana-Yi, C.论文数: 0 引用数: 0 h-index: 0机构: Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAZweidler-McKay, P.论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen Inc, Waltham, MA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMunteanu, M.论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen Inc, Waltham, MA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAAndreu-Vieyra, C.论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen Inc, Waltham, MA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAErba, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABlum, W.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USATraer, E.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [34] Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid LeukemiaBLOOD, 2018, 132Cortes, Jorge E.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USADeAngelo, Daniel J.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAErba, Harry P.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USATraer, Elie论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAPapadantonakis, Nikolaos论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAArana-Yi, Cecilia论文数: 0 引用数: 0 h-index: 0机构: Univ New Mexico, Albuquerque, NM 87131 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USABlum, William论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Dept Hematol & Oncol, Winship Canc Inst, Atlanta, GA 30322 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USASloss, Callum M.论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen, Waltham, MA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USACulm-Merdek, Kerry论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen, Waltham, MA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAZweidler-McKay, Patrick A.论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen, Waltham, MA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAWang, Eunice S.论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
- [35] CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123LEUKEMIA RESEARCH, 2024, 139Hu, Xiaoyi论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Canc Inst, Dept Med, Div Hematol, Stanford, CA 94305 USA Stanford Univ, Canc Inst, Dept Med, Div Hematol, Stanford, CA 94305 USA论文数: 引用数: h-index:机构:Saleem, Atif论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA Stanford Univ, Canc Inst, Dept Med, Div Hematol, Stanford, CA 94305 USATan, Brent论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Canc Inst, Dept Med, Div Hematol, Stanford, CA 94305 USA Stanford Univ, Canc Inst, Dept Med, Div Hematol, Stanford, CA 94305 USAPemmaraju, Naveen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Stanford Univ, Canc Inst, Dept Med, Div Hematol, Stanford, CA 94305 USAMannis, Gabriel N.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Canc Inst, Dept Med, Div Hematol, Stanford, CA 94305 USA Stanford Univ, Canc Inst, Dept Med, Div Hematol, Stanford, CA 94305 USA
- [36] A Phase I Study of IMGN529, an Antibody-Drug Conjugate (ADC) Targeting CD37, in Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)BLOOD, 2014, 124 (21)Stathis, Anastasios论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Bellinzona, Switzerland Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandFreedman, Arnold S.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandFlinn, Ian W.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandMaddocks, Kami J.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandWeitman, Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA CTRC Inst Drug Dev, San Antonio, TX USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandBerdeja, Jesus G.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandMejia, Alex V.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA CTRC Inst Drug Dev, San Antonio, TX USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandZucca, Emanuele论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Bellinzona, Switzerland Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandGreen, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandRomanelli, Angela论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen Inc, Waltham, MA USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandZildjian, Sybil H.论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen Inc, Waltham, MA USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandRuiz-Soto, Rodrigo论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen Inc, Waltham, MA USA Oncol Inst Southern Switzerland, Bellinzona, SwitzerlandPalomba, Lia论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Oncol Inst Southern Switzerland, Bellinzona, Switzerland
- [37] Efficacy Proof of Concept for Allogeneic CD123 Targeting CAR T-Cells Against Primary Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Efficient Control of Tumor Progression in PDX Model and Potential Loss of CD123 Expression in Relapsed DiseaseBLOOD, 2019, 134Cai, Tianyu论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USABlack, Kathryn L.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USANaqvi, Ammar S.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USATaylor, Deanne论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAZhao, Ming论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Sch Hlth Profess, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAYuan, Qi论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USASugita, Mayumi论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAGaletto, Roman论文数: 0 引用数: 0 h-index: 0机构: Cellectis SA, Paris, France Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAGouble, Agnes论文数: 0 引用数: 0 h-index: 0机构: Cellectis SA, Paris, France Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USASmith, Julianne N. P.论文数: 0 引用数: 0 h-index: 0机构: Cellectis Inc, New York, NY USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USACavazos, Antonio论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAHan, Lina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAZhang, Qi论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAKuruvilla, Vinitha Mary论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAMa, Helen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAKonoplev, Sergej论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USATang, Guilin论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAGu, Jun论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Sch Hlth Profess, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USASu, Xiaoping论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USANeelapu, Sattva S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USALane, Andrew A.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAKantarjian, Hagop M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAGuzman, Monica L.论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAPemmaraju, Naveen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAThomas-Tikhonenko, Andrei论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAKonopleva, Marina Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
- [38] BYON4413, an in vivo active CD123-targeting antibody-drug conjugate, combines effectively with azacitidine and venetoclax in acute myeloid leukemia cell linesCANCER RESEARCH, 2024, 84 (06)van der Lee, Miranda M. C.论文数: 0 引用数: 0 h-index: 0van Achterberg, Tanja论文数: 0 引用数: 0 h-index: 0Hersmus, Kaylee论文数: 0 引用数: 0 h-index: 0Brouwers-Vos, Annet论文数: 0 引用数: 0 h-index: 0van der Vleuten, Monique论文数: 0 引用数: 0 h-index: 0Pruis, Maurien论文数: 0 引用数: 0 h-index: 0Kappers, Wendy论文数: 0 引用数: 0 h-index: 0Verheijden, Gijs论文数: 0 引用数: 0 h-index: 0Huls, Gerwin论文数: 0 引用数: 0 h-index: 0van Wigcheren, Glenn论文数: 0 引用数: 0 h-index: 0Ubink, Ruud论文数: 0 引用数: 0 h-index: 0Sesink, Aloys论文数: 0 引用数: 0 h-index: 0MacInnes, Alyson论文数: 0 引用数: 0 h-index: 0Schuringa, Jan Jacob论文数: 0 引用数: 0 h-index: 0Dokter, Wim论文数: 0 引用数: 0 h-index: 0
- [39] IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid LeukemiaBLOOD, 2017, 130Cortes, Jorge E.论文数: 0 引用数: 0 h-index: 0Traer, Elie论文数: 0 引用数: 0 h-index: 0Wang, Eunice S.论文数: 0 引用数: 0 h-index: 0Erba, Harry P.论文数: 0 引用数: 0 h-index: 0Blum, William论文数: 0 引用数: 0 h-index: 0Arana-Yi, Cecilia论文数: 0 引用数: 0 h-index: 0Sloss, Callum M.论文数: 0 引用数: 0 h-index: 0Culm-Merdek, Kerry论文数: 0 引用数: 0 h-index: 0Towles, Jeanette论文数: 0 引用数: 0 h-index: 0Zweidler-McKay, Patrick A.论文数: 0 引用数: 0 h-index: 0DeAngelo, Daniel J.论文数: 0 引用数: 0 h-index: 0
- [40] Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumorsINVESTIGATIONAL NEW DRUGS, 2016, 34 (03) : 290 - 299Shah, Manisha H.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Coll Med, Columbus, OH 43210 USA Ohio State Univ, Coll Med, Columbus, OH 43210 USA论文数: 引用数: h-index:机构:O'Brien, Mary E. R.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Downs Rd, Sutton SM2 5PT, Surrey, England Ohio State Univ, Coll Med, Columbus, OH 43210 USAFossella, Frank V.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, Div Canc Med, Houston, TX 77030 USA Ohio State Univ, Coll Med, Columbus, OH 43210 USAMoore, Kathleen N.论文数: 0 引用数: 0 h-index: 0机构: Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA Ohio State Univ, Coll Med, Columbus, OH 43210 USABhatia, Shailender论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Sch Med, Dept Med, Seattle, WA 98109 USA Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA Ohio State Univ, Coll Med, Columbus, OH 43210 USAKirby, Maurice论文数: 0 引用数: 0 h-index: 0机构: ImmunoGen Inc, Waltham, MA 02451 USA Ohio State Univ, Coll Med, Columbus, OH 43210 USAWoll, Penella J.论文数: 0 引用数: 0 h-index: 0机构: Univ Sheffield, Weston Pk Hosp, Acad Unit Clin Oncol, Whitham Rd, Sheffield S10 2SJ, S Yorkshire, England Ohio State Univ, Coll Med, Columbus, OH 43210 USA